A Prospective Single Institution Study of Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab
Latest Information Update: 14 Dec 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 29 Nov 2021 Status changed from recruiting to withdrawn prior to enrolment.
- 12 Apr 2011 New trial record